This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company’s Interim President and Chief Executive Officer, and Shawn McCormick, the Company’s Chief Financial Officer, will be presenting at the 2013 RBC Capital Markets Global Healthcare Conference.
The Company’s presentation is scheduled for Wednesday, February 27, at 2:30 p.m. Eastern time at The New York Palace in NYC.
The presentation will be webcast live on the Investor Relations section of the Company’s website at
www.tornier.com. For those who are not available to listen to the live webcast, a replay will be archived for one year.
Tornier is a global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company’s broad offering of over 100 product lines includes joint replacement, trauma, sports medicine, and ortho-biologic products through Tornier and OrthoHelix brands to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier’s “Specialists Serving Specialists” philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopaedic technology stemming from its close collaboration with orthopaedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit
www.tornier.com, or OrthoHelix, visit